Title:

To improve the bioavailability of Proton pump Inhibitors, in particular by preventing gastric degradation, various oral formulations of Proton pump Inhibitors such as enteric coated granules and tablets have been developed1. PPIs are better antisecretory agents than H2 receptor antagonists (H2-RAs) 2, 3. ................
................